NYSE American - Nasdaq Real Time Price USD
Impact BioMedical Inc. (IBO)
0.5049
-0.0053
(-1.05%)
As of 12:25:42 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
50
50
Operating Expense
3,397
3,397
4,028
3,454
3,454
Operating Income
-3,397
-3,397
-4,028
-3,404
-3,404
Net Non Operating Interest Income Expense
-1,052
-1,052
-431
-438
-438
Other Income Expense
-20,288
-20,288
52
-4,034
-4,034
Pretax Income
-24,737
-24,737
-4,407
-7,876
-7,876
Tax Provision
33
33
0
-621
-621
Net Income Common Stockholders
-24,708
-24,708
-4,336
-7,051
-7,051
Diluted NI Available to Com Stockholders
-24,708
-24,708
-4,336
-7,051
-7,051
Basic EPS
0.10
-2.30
-0.07
-0.61
-0.61
Diluted EPS
0.10
-2.30
-0.07
-0.61
-0.61
Basic Average Shares
11,503.9550
10,757.1470
60,248.0780
11,497.7030
11,497.7030
Diluted Average Shares
11,503.9550
10,757.1470
60,248.0780
11,497.7030
60,248.0780
Total Operating Income as Reported
-28,753
-28,753
-4,028
-3,404
-3,404
Rent Expense Supplemental
32
32
--
--
--
Total Expenses
3,397
3,397
4,028
3,454
3,454
Net Income from Continuing & Discontinued Operation
-24,708
-24,708
-4,336
-7,051
-7,051
Normalized Income
-4,676.7600
-4,676.7600
-4,336
-3,274.9000
-3,274.9000
Interest Income
13
13
13
24
24
Interest Expense
1,065
1,065
444
462
462
Net Interest Income
-1,052
-1,052
-431
-438
-438
EBIT
-23,672
-23,672
-3,963
-7,414
-7,414
EBITDA
-22,553
-22,553
-2,843
-6,301
-6,301
Reconciled Depreciation
1,119
1,119
1,120
1,113
1,113
Net Income from Continuing Operation Net Minority Interest
-24,708
-24,708
-4,336
-7,051
-7,051
Total Unusual Items Excluding Goodwill
-25,356
-25,356
0
-4,100
-4,100
Total Unusual Items
-25,356
-25,356
0
-4,100
-4,100
Normalized EBITDA
2,803
2,803
-2,843
-2,201
-2,201
Tax Rate for Calcs
0.0002
0.0002
0
0.0001
0.0001
Tax Effect of Unusual Items
-5,324.7600
-5,324.7600
0
-323.9000
-323.9000
12/31/2021 - 9/16/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SPRC SciSparc Ltd.
0.3396
+9.55%
KTTA Pasithea Therapeutics Corp.
1.0398
-7.98%
NCNA NuCana plc
0.1055
-64.96%
PLRZ Polyrizon Ltd.
0.6744
+3.27%
ADIL Adial Pharmaceuticals, Inc.
0.6092
-6.42%
RNAZ TransCode Therapeutics, Inc.
0.3235
-8.92%
ZVSA ZyVersa Therapeutics, Inc.
0.5771
-15.73%
GLMD Galmed Pharmaceuticals Ltd.
1.2300
-4.65%
TOVX Theriva Biologics, Inc.
0.6701
-17.27%
HEPA Hepion Pharmaceuticals, Inc.
0.3962
+1.59%